Monthly DBM Research Group Seminar
Chiara Borsari and Erhan Keles, Cancer- and Immunobiology (Wymann group)
From pan- to PI3Kα Inhibitors: a Covalent Strategy / Novel PI3Kα Inhibitors – Innovative Pharmacology in PI3K-targeted Cancer Therapy?
Export event as
iCal
